Literature DB >> 1465454

High expression of human beta S- and alpha-globins in transgenic mice: hemoglobin composition and hematological consequences.

M E Fabry1, R L Nagel, A Pachnis, S M Suzuka, F Costantini.   

Abstract

A line of transgenic mice (alpha H beta S-11; where alpha H is human alpha-globin) was created in which the human beta S and human alpha 2 globin genes, each linked to the beta-globin locus control region, were cointegrated into the mouse genome. On a normal genetic background, the transgenic mice produced 36% human beta S-globin chains with an alpha H/beta S ratio of 1.3. Higher levels of beta S were achieved by breeding the transgenic mice with mutant mice carrying a mouse beta major-globin gene deletion. Mice heterozygous for the beta major deletion (alpha H beta S[beta MD]; MD, mouse deletion) had 54% beta S with an alpha H/beta S ratio of 1.0; mice homozygous for the beta major deletion (alpha H beta S[beta MDD]) had 72.5% beta S and an alpha H/beta S ratio of 0.73. Because mouse alpha chains inhibit hemoglobin (Hb) S polymerization, we bred the mice to heterozygosity for a mouse alpha-globin deletion. These mice (alpha H beta S[alpha MD beta MDD]) had an increased alpha H/beta S ratio of 0.89 but expressed 65% beta S. Expression of the human genes cured the thalassemic phenotype associated with the murine beta major deletion. Transgenic alpha H beta S[beta MDD] mice had normal hematocrit and Hb and somewhat elevated reticulocytes (6% vs. 3% for control), whereas the mice carrying the alpha-globin deletion (alpha H beta S[alpha MD beta MDD]) had a normal hematocrit and Hb and more elevated reticulocytes (10.3 +/- 7.6% vs. 3.4 +/- 1.0%). Expression of the transgene restored a normal distribution of erythrocyte densities when compared to thalassemic mice; however, the average mean corpuscular Hb concentration of alpha H beta S[beta MDD] mice increased to 35.7 g/dl (vs. control 33.7 g/dl) whereas that of alpha H beta S[alpha MD beta MDD] mice was further elevated to 36.3 g/dl. The intrinsic oxygen affinity was increased in transgenic mouse erythrocytes at 280 milliosmolal, and the PO2 at midsaturation of alpha H beta S[alpha MD beta MDD] erythrocytes was higher than that of alpha H beta S[beta MDD] cells (37.4 +/- 2 vs. 33.5 +/- 1 mmHg). The higher values of the mean corpuscular Hb concentration and intrinsic PO2 at midsaturation, which favor in vivo sickling, may explain the slightly more severe hematological picture in alpha H beta S[alpha MD beta MDD] mice. We conclude that the transgenic mouse with high Hb S expression does not exhibit adult anemia but does have abnormal hematological features: increased erythrocyte density, high oxygen affinity, and reticulocytosis with increased stress reticulocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465454      PMCID: PMC50716          DOI: 10.1073/pnas.89.24.12150

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Primary Polydipsia and Hydronephrosis in an Inbred Strain of Mice.

Authors:  E Silverstein; L Sokoloff; O Mickelsen; G E Jay
Journal:  Am J Pathol       Date:  1961-02       Impact factor: 4.307

2.  Gelation of sickle cell hemoglobin in mixtures with normal adult and fetal hemoglobins.

Authors:  H R Sunshine; J Hofrichter; W A Eaton
Journal:  J Mol Biol       Date:  1979-10-09       Impact factor: 5.469

3.  Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids.

Authors:  W C Forrester; S Takegawa; T Papayannopoulou; G Stamatoyannopoulos; M Groudine
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

4.  High-level, erythroid-specific expression of the human alpha-globin gene in transgenic mice and the production of human hemoglobin in murine erythrocytes.

Authors:  O Hanscombe; M Vidal; J Kaeda; L Luzzatto; D R Greaves; F Grosveld
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

5.  Rheological studies of erythrocyte-endothelial cell interactions in sickle cell disease.

Authors:  G A Barabino; L V McIntire; S G Eskin; D A Sears; M Udden
Journal:  Prog Clin Biol Res       Date:  1987

6.  A transgenic mouse model of sickle cell disorder.

Authors:  D R Greaves; P Fraser; M A Vidal; M J Hedges; D Ropers; L Luzzatto; F Grosveld
Journal:  Nature       Date:  1990-01-11       Impact factor: 49.962

7.  High performance liquid chromatographic separation of the globin chains of non-human hemoglobins.

Authors:  W A Schroeder; J B Shelton; J R Shelton; V Huynh; D B Teplow
Journal:  Hemoglobin       Date:  1985       Impact factor: 0.849

8.  Synthesis of functional human hemoglobin in transgenic mice.

Authors:  R R Behringer; T M Ryan; M P Reilly; T Asakura; R D Palmiter; R L Brinster; T M Townes
Journal:  Science       Date:  1989-09-01       Impact factor: 47.728

9.  A mouse model for beta-thalassemia.

Authors:  L C Skow; B A Burkhart; F M Johnson; R A Popp; D M Popp; S Z Goldberg; W F Anderson; L B Barnett; S E Lewis
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

10.  Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD.

Authors:  M Trudel; N Saadane; M C Garel; J Bardakdjian-Michau; Y Blouquit; J L Guerquin-Kern; P Rouyer-Fessard; D Vidaud; A Pachnis; P H Roméo
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

View more
  35 in total

1.  Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.

Authors:  D K Kaul; R P Hebbel
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease.

Authors:  Renata Polanowska-Grabowska; Kori Wallace; Joshua J Field; Lanlin Chen; Melissa A Marshall; Robert Figler; Adrian R L Gear; Joel Linden
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

3.  Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Ping Zhang; Fuad Abdulla; Phong Nguyen; Trevor Killeen; Pauline Xu; Gerry O'Sullivan; Karl A Nath; Gregory M Vercellotti
Journal:  Antioxid Redox Signal       Date:  2016-03-30       Impact factor: 8.401

4.  A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.

Authors:  Qiuying Chen; Mary E Fabry; Anne C Rybicki; Sandra M Suzuka; Tatiana C Balazs; Zipora Etzion; Kitty de Jong; Edna K Akoto; Joseph E Canterino; Dhananjay K Kaul; Frans A Kuypers; David Lefer; Eric E Bouhassira; Rhoda Elison Hirsch
Journal:  Blood Cells Mol Dis       Date:  2012-01-18       Impact factor: 3.039

5.  Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease.

Authors:  K A Nath; J P Grande; J J Haggard; A J Croatt; Z S Katusic; A Solovey; R P Hebbel
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

6.  Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease.

Authors:  Narendranath Reddy Chintagari; Julia Nguyen; John D Belcher; Gregory M Vercellotti; Abdu I Alayash
Journal:  Blood Cells Mol Dis       Date:  2014-12-22       Impact factor: 3.039

7.  Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia.

Authors:  P V Browne; O Shalev; F A Kuypers; C Brugnara; A Solovey; N Mohandas; S L Schrier; R P Hebbel
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

Review 8.  Targeting pain at its source in sickle cell disease.

Authors:  Kanika Gupta; Om Jahagirdar; Kalpna Gupta
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-28       Impact factor: 3.619

Review 9.  Innate T cells in the intensive care unit.

Authors:  Edy Yong Kim; William M Oldham
Journal:  Mol Immunol       Date:  2018-12-13       Impact factor: 4.407

10.  Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.

Authors:  Gregory M Vercellotti; Ping Zhang; Julia Nguyen; Fuad Abdulla; Chunsheng Chen; Phong Nguyen; Carlos Nowotny; Clifford J Steer; Ann Smith; John D Belcher
Journal:  Mol Med       Date:  2016-07-19       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.